Diabetes is one of the leading causes of death. Patients with type 1 diabetes have their insulin secreting cells destroyed by the immune system and require daily insulin injections. Pancreatic islet transplantation is an effective treatment that can dramatically reduce daily doses or even eliminate dependence on external insulin. Insulin producing cells are injected into a recipient liver. After an adaptation period they start to produce sufficient hormone needed by diabetic patients.
However, while the transplantation procedure itself has been greatly improved in recent years, collection, preservation, and transportation of these cells are still very challenging. Research published in Advanced Healthcare Materials by the scientists from the Okinawa Institute of Technology and Science Graduate University (OIST) in collaboration with the University of Washington and Wuhan University of Technology offers a solution for some of these problems.
Production and secretion of insulin occur in the pancreas — an endocrine gland in the digestive system. Cells secreting insulin are clustered in pancreatic islets. Despite their crucial role in organismal wellbeing these islets comprise only a few percent of the pancreatic tissue. The islet transplantation does not require major surgical intervention and is often done under local anaesthesia. It is also cheaper and might be safer than transplantation of the entire pancreas. Unfortunately, so far, only human islets can be transplanted and their supply is but a trickle.
Cryopreservation, or deep freezing, is the method commonly used for the islet preservation and transportation. But it is not completely safe. One might think that storage at temperatures below -190°C is the most dangerous phase. However, the cells are very good at enduring it. It is the freezing process (-15 to -60°C) itself that poses the most challenges. As the cells are cooled, water in and around them freezes. Ice crystals have sharp edges that can pierce membranes and compromise cell viability. This also becomes problematic during thawing.
A multidisciplinary group of researchers led by Prof. Amy Shen, head of the Micro/Bio/Nanofluidics Unit at OIST, developed a novel cryopreservation method that not only helps to protect pancreatic islets from ice damage, but also facilitates real-time assessments of cell viability. Moreover, this method may reduce transplant rejection and, in turn, decrease use of immunosuppressant drugs, which can be harmful to patient health.
The novel technique employs a droplet microfluidic device to encapsulate pancreatic islets in hydrogel made of alginate, a natural polymer extracted from seaweed. These capsules have a unique microstructure: a porous network and considerable amount of non-freezable water. There are three types of water in the hydrogel: free water, freezable bound water, and non-freezable bound water. Free water is regular water: it freezes at 0°C, producing ice crystals. Freezable bound water also crystallises, but the freezing point is lower. Non-freezable bound water does not form ice due to the strong association between water molecules and the hydrogel networks. Hydrogel capsules with large amounts of non-freezable bound water protect the cells from the ice damage and reduce the need for cryoprotectants — special substances that minimise or prevent freezing damage and can be toxic in high concentrations.
Another innovation, proposed by the group, is the use of a fluorescent oxygen-sensitive dye in hydrogel capsules. The porous structure of the capsules does not impede oxygen flow to the cells. And this dye functions as a real-time single-islet oxygen sensor. Fluorescence indicates whether cells are consuming oxygen and, therefore, are alive and healthy. It is a simple, time-efficient, and cheap method of assessing viability, both of individual islets or populations thereof.
Islet encapsulation reduces the risk of rejection of transplanted cells by the recipient. The hydrogel capsule allows small molecules, e.g. nutrients and islet secretions, to pass through the membrane easily, but prevents direct contact between implanted islets and host cells. Encapsulation also may prevent an attack on transplants by the autoimmune response that destroyed the patient’s own islets in the first place.
The microencapsulation method can help to overcome some major challenges in pancreatic islet transplantation, including the scarcity of available islets and the lack of simple and reliable control methods, especially for individual islet assessment. It offers hope to patients suffering from type 1 diabetes to return to a “normal” life, free of insulin injections.
The Latest on: Diabetes
[google_news title=”” keyword=”diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Diabetes
- Carmot Readies IPO to Seize Bulging Obesity and Diabetes Marketon November 27, 2023 at 11:02 am
Gloomy clouds may still hang thick over the initial public offering (IPO) market, but some companies are still wading into the listing ...
- Stem cell-based treatment controls blood sugar in people with type 1 diabetes: Clinical trialon November 27, 2023 at 9:58 am
An innovative stem cell-based treatment for type 1 diabetes can meaningfully regulate blood glucose levels and reduce dependence on daily insulin injections, according to new clinical trial results ...
- Eye-opening facts about diabetes you need to knowon November 27, 2023 at 9:15 am
Mabunda also stressed the importance of regular health checks that can detect warning signs of diabetes. He also encouraged engaging in healthy lifestyle behaviours, such as regular physical activity, ...
- Unraveling the mystery that is diabeteson November 27, 2023 at 8:00 am
Have you had your blood sugar checked lately? If you have a family history, have a sedentary lifestyle, suffer from obesity, feel tired and always thirsty — maybe it’s about time you do. Because the ...
- Denied long-term disability for diabetes? 3 things you must doon November 27, 2023 at 3:00 am
If your insurer rejects your LTD claim for diabetes, don’t appeal the decision before seeking legal advice, say disability lawyers.
- Ozempic shortage impact on Canadian patients with Type 2 diabeteson November 26, 2023 at 6:19 pm
Some people living with diabetes say they're being forced to switch their medication because of a shortage of Ozempic. The drug is approved for the treatment of Type 2 diabetes, but is also prescribed ...
- 12 Best Diabetes Stocks To Buy Nowon November 26, 2023 at 12:11 pm
In this article, we shall discuss the 12 best diabetes stocks to buy now. To skip our detailed analysis of the global diabetes drugs industry in 2023, go directly and see 5 Best Diabetes Stocks to Buy ...
- Ottawa man calling for limits on off-label prescriptions for diabetes medicationon November 26, 2023 at 8:50 am
An Ottawa man is trying to bring more awareness about the shortage of diabetes drugs that have become popular weight-loss tools to Parliament.
- Take charge of your diabeteson November 26, 2023 at 6:00 am
By visiting your doctor regularly and prioritizing your health, you can take charge of your diabetes. Early recognition and intervention can prevent complications and promote better overall health for ...
- Ask a doctor: Is it possible to reverse my diabetes?on November 26, 2023 at 6:00 am
Unlock the path to Type 2 diabetes reversal—explore hope, challenges, and effective sugar control strategies for a healthier life.
via Bing News